Honey and Nigella Sativa in COVID-19 Prophylaxis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ahmad Imran, MBBS
Shaikh Zayed Post-Graduate Medical Institute
Principal Investigator - Moneeb Ashraf, MBBS
King Edward Medical University
Principal Investigator - Muhammad Ashraf, PhD
University of Veterinary and Animal Sciences
Study Chair - Sohaib Ashraf, MBBS
Massachusetts General Hospital
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Shaikh Zayed Post-Graduate Medical Institute
Lahore, MA, Pakistan
Iqra Farooq, MBBSLarab Kalsoom, MBBSMaaz Akram, MBBSShahroze Arshad, MBBSUzma N Siddique, MBBSRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Mar 2021
- Primary completion
- 15 Feb 2022
- Completion
- 15 Apr 2022
- Last update posted
- 2 Jul 2021
- Registered enrollment
- 1,000
- Registry id
- NCT04767087
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.